Literature DB >> 7042548

Solubilization of an activity regulating C3b function from Raji cell membranes.

P Carlson, S Ruddy, D H Conrad.   

Abstract

A fraction of isolated Raji cell membranes solubilized with 2m KBr which was capable of inhibiting C3-dependent rosettes was examined for its ability to inhibit the alternative pathway of complement. It was shown to decrease alternative pathway-dependent haemolysis of sheep erythrocytes and to accelerate decay of factor B from these cells. It had no effect on C2 decay, the classical pathway analog of factor B. Inhibitory activity solubilized from Raji cells was not removed by immunoadsorption with anti-factor H or anti-factor I, two well-characterized serum C3b-control proteins. It also differed in two functional respects from these proteins. Firstly, it failed to result in cleavage of a peptide bone in C3 which is characteristic of factor I; secondly, its inhibitory activity did not synergize with factor I in inhibiting the alternative pathway, unlike factor H. These results suggest that Raji cells contain a regulatory factor in their membranes for the alternative pathway of complement which is distinct from factors H and I.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042548      PMCID: PMC1555332     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

2.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

3.  Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

Authors:  L G Hunsicker; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

4.  The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.

Authors:  I Gigli; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

7.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

8.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

9.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.